Krishna Institute of Medical Sciences Ltd
NSE:KIMS
KIMS's latest stock split occurred on Sep 13, 2024
The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.
Before the split, KIMS traded at 2735.9 per share. Afterward, the share price was about 552.35.
The adjusted shares began trading on Sep 13, 2024. This was the only stock split in KIMS's history.
1S9
Krishna Institute of Medical Sciences Ltd
Glance View
Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions. The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.
You don't have any saved screeners yet